| Original language | Italian |
|---|---|
| Pages (from-to) | 310-317 |
| Journal | Haematologica |
| Volume | 97 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 1 Feb 2012 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. / Sureda, A; Canals, C; Arranz, R; Caballero, D; Ribera, JM; Brune, M; Passweg, J; Martino, R; Valcárcel, D; Besalduch, J; Duarte, R; León, A; Pascual, MJ; García-Noblejas, A; López, Corral L; Xicoy, B; Sierra, J; Schmitz, N.
In: Haematologica, Vol. 97, No. 2, 01.02.2012, p. 310-317.Research output: Contribution to journal › Article › Research
TY - JOUR
T1 - Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
AU - Sureda, A
AU - Canals, C
AU - Arranz, R
AU - Caballero, D
AU - Ribera, JM
AU - Brune, M
AU - Passweg, J
AU - Martino, R
AU - Valcárcel, D
AU - Besalduch, J
AU - Duarte, R
AU - León, A
AU - Pascual, MJ
AU - García-Noblejas, A
AU - López, Corral L
AU - Xicoy, B
AU - Sierra, J
AU - Schmitz, N.
PY - 2012/2/1
Y1 - 2012/2/1
U2 - https://doi.org/10.3324/haematol.2011.045757
DO - https://doi.org/10.3324/haematol.2011.045757
M3 - Artículo
VL - 97
SP - 310
EP - 317
IS - 2
ER -